Patrick Onwuasor
Linebacker
Age: 28
Free Agency: 2021 (UFA)
Accrued Seasons: 4
- Height: 6-0
- Weight: 213
- College: Portland State
- Entry: 2016 Undrafted Free Agent (Ravens)
- 2020 Salary Cap Charge: $2,000,000 (0.95% of cap)
- 2020 Cash Payout: $2,000,000 (1.06% of spending)
- 2020 Cash to Cap Ratio: 1.00
- Contract Value: $2,000,000 ($2,000,000 APY)
- Fully Guaranteed Money: $2,000,000
- Contract Ranking: 90/347 at LB
Current Contract
(UFA, signed 2020)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Prorated Bonus | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 28 | $1,000,000 | $1,000,000 | $1,000,000 | $2,000,000 | 1.0% | |||||
| Total | $1,000,000 | $1,000,000 | $1,000,000 | $2,000,000 | |||||||
Contract Notes
Patrick Onwuasor signed a $2 million contract with the Jets. Onwuasors contract is fully guaranteed.Career Earnings: $5,582,647
Career APY: $1,395,662
Potential Earnings: $6,582,647
Total Guarantees: $2,000,000
Largest Cash Payment: $3,095,000 (2019)
Largest Cap Number: $3,095,000 (2019)
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Ravens | ERFA | Expired | 2017 | 1 | $540,000 | $540,000 | $0 | $540,000 | 100.0% | $540,000 |
| Ravens | ERFA | Expired | 2018 | 1 | $630,000 | $630,000 | $0 | $630,000 | 100.0% | $630,000 |
| Ravens | RFA | Expired | 2019 | 1 | $3,095,000 | $3,095,000 | $0 | $3,095,000 | 100.0% | $3,095,000 |
| Jets | UFA | Active | 2020 | 1 | $2,000,000 | $2,000,000 | $2,000,000 | $1,000,000 | 50.0% | $0 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Ravens | 4 | $4,582,647 | $1,145,662 | $4,582,647 | 0.0% | $39,500 | 0.0% |
| Jets | 0 | $1,000,000 | $0 | $0 | 0.0% | $0 | 0.0% |
Salary Cap History
| Year | Team | Base Salary | Prorated Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|
| 2016 | Ravens | $450,000 | $0 | $0 | $317,647 | 0.2% | $317,647 | ||
| 2017 | Ravens | $540,000 | $0 | $0 | $540,000 | 0.3% | $540,000 | ||
| 2018 | Ravens | $630,000 | $0 | $0 | $630,000 | 0.4% | $630,000 | ||
| 2019 | Ravens | $3,095,000 | $0 | $0 | $3,095,000 | 1.6% | $3,095,000 | ||
| 2020 | Jets | $1,000,000 | $1,000,000 | $1,000,000 | $2,000,000 | 1.0% | $2,000,000 | ||
| Total | $5,715,000 | $1,000,000 | $1,000,000 | $6,582,647 | $6,582,647 | ||||
Statistics
| Year | Games Played | Games Missed | Snaps | Tackles | Negative Plays | Interceptions | Fumbles | TD | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injured | Healthy | Defense | Special | Solo | Assist | Sacks | Yards | TFL | QB Hits | Pass Def. | INT | Yards | Forced | Rec. | Yards | |||
| 2016 | 11 | 0 | 0 | 5.7% | 52.0% | 8 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| 2017 | 16 | 0 | 0 | 59.2% | 29.3% | 62 | 22 | 1 | 1 | 4 | 1 | 2 | 0 | 0 | 1 | 1 | 0 | 0 |
| 2018 | 16 | 0 | 0 | 41.9% | 44.6% | 37 | 22 | 5.5 | 43.5 | 8 | 12 | 3 | 1 | 33 | 2 | 0 | 0 | 0 |
| 2019 | 14 | 2 | 0 | 48.4% | 11.4% | 48 | 17 | 3 | 23 | 5 | 6 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $667,000 | $2,000,000 |
| Injury Adjusted | $1,011,492 | $1,750,000 |
test
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.